A pharmacokinetic and pharmacodynamic comparison of a novel pegylated recombinant consensus interferon-α variant with peginterferon-α-2a in healthy subjects. | Semantic Scholar
Adjustment during Peg-IFN treatment for HBeAg-negative CHB patients.... | Download Scientific Diagram
JCM | Free Full-Text | Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens
Add-on, switch-to PEG-IFN therapy strategies improve serological response in CHB patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
PEG-IFN-ALPHA - Pegylated Interferon-alpha
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | Scientific Reports
Average PEG-IFN concentration in serum. Data correspond to 15 healthy... | Download Scientific Diagram
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study - ScienceDirect
Chronic treatment with peg-IFN-α reduces peripheral disease parameters... | Download Scientific Diagram
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C - ScienceDirect
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Frontiers | Interferon and Hepatitis B: Current and Future Perspectives
JCM | Free Full-Text | Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens
Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155 - ScienceDirect
Peg-INF Inj 180mcg Pack of 4 – Ailaaj
PEG-IFN mechanism in HCV infection (Wong and Chen, 2016). | Download Scientific Diagram
Full article: Interferon dimers: IFN-PEG-IFN
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
ASPIRE Study: SMV + PEG-IFN + RBV for genotype 1 experienced patients - ppt download
EORTC Melanoma Group Investigating Use Of PEG-IFN- α-2b For Patients With Stage II Ulcerated Primary Cutaneous Melanoma 2024 - EORTC
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | Scientific Reports
In Vivo Pharmacology and Toxicology Evaluation of Polyethylene Glycol-Conjugated Interferon β-1a | Journal of Pharmacology and Experimental Therapeutics
Peg-INF Inj 180mcg 1Vial
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
Differences on the PEGylation strategy for PegIntron ® (PEG-IFN2b) and... | Download Scientific Diagram
PEG-IFN-ALPHA - Pegylated Interferon-alpha
